Cargando…

Mixed Pathologies in a Subject with a Novel PSEN1 G206R Mutation

BACKGROUND: There are more than 300 presenilin-1 (PSEN1) mutations identified but a thorough postmortem neuropathological assessment of the mutation carriers is seldom performed. OBJECTIVE: To assess neuropathological changes (NC) in a 73-year-old subject with the novel PSEN1 G206R mutation sufferin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Libard, Sylwia, Giedraitis, Vilmantas, Kilander, Lena, Ingelsson, Martin, Alafuzoff, Irina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789486/ https://www.ncbi.nlm.nih.gov/pubmed/36314207 http://dx.doi.org/10.3233/JAD-220655

Ejemplares similares

In vivo Characterization of Biochemical Variants of Amyloid-β in Subjects with Idiopathic Normal Pressure Hydrocephalus and Alzheimer’s Disease Neuropathological Change
por: Libard, Sylwia, et al.
Publicado: (2021)

Alzheimer’s disease neuropathological change and loss of matrix/neuropil in patients with idiopathic Normal Pressure Hydrocephalus, a model of Alzheimer’s disease
por: Libard, Sylwia, et al.
Publicado: (2019)

Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia
por: Pagnon de la Vega, María, et al.
Publicado: (2022)

Characteristics of the tissue section that influence the staining outcome in immunohistochemistry
por: Libard, Sylwia, et al.
Publicado: (2018)

Dual-task tests discriminate between dementia, mild cognitive impairment, subjective cognitive impairment, and healthy controls – a cross-sectional cohort study
por: Åhman, Hanna B., et al.
Publicado: (2020)

APOE ε4 allele, along with G206D-PSEN1 mutation, alters mitochondrial networks and their degradation in Alzheimer’s disease
por: Costa-Laparra, Irene, et al.
Publicado: (2023)

CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation
por: Konstantinidis, Evangelos, et al.
Publicado: (2022)

Dual-Task Tests Predict Conversion to Dementia—A Prospective Memory-Clinic-Based Cohort Study
por: B Åhman, Hanna, et al.
Publicado: (2020)

Cognitive function in very old men does not correlate to biomarkers of Alzheimer’s disease
por: Velickaite, V., et al.
Publicado: (2017)

Altered Proteins in the Aging Brain
por: Elobeid, Adila, et al.
Publicado: (2016)

Dual-Task Performance and Neurodegeneration: Correlations Between Timed Up-and-Go Dual-Task Test Outcomes and Alzheimer’s Disease Cerebrospinal Fluid Biomarkers
por: Åhman, Hanna Bozkurt, et al.
Publicado: (2019)

The R278I Mutation of PSEN1 in the Familial Alzheimer Disease
por: Kim, Jong Hun, et al.
Publicado: (2020)

APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease
por: Giau, Vo Van, et al.
Publicado: (2019)

Improved Differential Diagnosis of Alzheimer’s Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers
por: Khoonsari, Payam Emami, et al.
Publicado: (2019)

Italian Case Report with a Double Mutation in PSEN1 (K311R and E318G)
por: Bisceglia, Paola, et al.
Publicado: (2022)

The value of magnetic resonance spectroscopy as a supplement to MRI of the brain in a clinical setting
por: Hellström, Jussi, et al.
Publicado: (2018)

At R206
por: CERN PhotoLab
Publicado: (1976)

Amyloid-β(1–43) cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations
por: Perrone, Federica, et al.
Publicado: (2020)

Different Inflammatory Signatures in Alzheimer’s Disease and Frontotemporal Dementia Cerebrospinal Fluid
por: Boström, Gustaf, et al.
Publicado: (2021)

Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community Cohorts
por: Nowak, Christoph, et al.
Publicado: (2016)

Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer’s disease variants: AβPParc and PSEN1DE9
por: Lemoine, Laetitia, et al.
Publicado: (2020)

Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro
por: Raut, Snehal, et al.
Publicado: (2021)

Novel PSEN1 and PSEN2 Mutations Identified in Sporadic Early-onset Alzheimer Disease and Posterior Cortical Atrophy
por: Li, Xu-Ying, et al.
Publicado: (2021)

Timed Up-and-Go Dual-Task Testing in the Assessment of Cognitive Function: A Mixed Methods Observational Study for Development of the UDDGait Protocol
por: Cedervall, Ylva, et al.
Publicado: (2020)

Astrocytic uptake of neuronal corpses promotes cell-to-cell spreading of tau pathology
por: Mothes, Tobias, et al.
Publicado: (2023)

Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2
por: Hsu, Simon, et al.
Publicado: (2020)

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
por: Lanoiselée, Hélène-Marie, et al.
Publicado: (2017)

Mast Cell Infiltration in Human Brain Metastases Modulates the Microenvironment and Contributes to the Metastatic Potential
por: Roy, Ananya, et al.
Publicado: (2017)

Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease
por: Dumanski, Jan P., et al.
Publicado: (2016)

Novel PSEN1 G209A mutation in early-onset Alzheimer dementia supported by structural prediction
por: An, Seong Soo A., et al.
Publicado: (2016)

Pathogenic Aβ production by heterozygous PSEN1 mutations is intrinsic to the mutant protein and not mediated by conformational hindrance of wild-type PSEN1
por: Kurth, Vanessa, et al.
Publicado: (2023)

PSEN as an Educational Tool in Norway
por: Westvik, Tormod Schumacher
Publicado: (2017)

Identification of two novel mutations, PSEN1 E280K and PRNP G127S, in a Malaysian family
por: Ch’ng, Gaik-Siew, et al.
Publicado: (2015)

Hyperphosphorylated tau in young and middle-aged subjects
por: Elobeid, Adila, et al.
Publicado: (2011)

Characterization of spastic paraplegia in a family with a novel PSEN1 mutation
por: Ringman, John M, et al.
Publicado: (2023)

Presenilin-1 (PSEN1) Mutations: Clinical Phenotypes beyond Alzheimer’s Disease
por: Yang, Youngsoon, et al.
Publicado: (2023)

Neurophysiological alterations in mice and humans carrying mutations in APP and PSEN1 genes
por: van Heusden, Fran C., et al.
Publicado: (2023)

From EST to structure models for functional inference of APP, BACE1, PSEN1, PSEN2 genes
por: Aathi, Muthusankar, et al.
Publicado: (2019)

APP, PSEN1, and PSEN2 Variants in Alzheimer’s Disease: Systematic Re-evaluation According to ACMG Guidelines
por: Xiao, Xuewen, et al.
Publicado: (2021)

Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4
por: Pollen, Daniel A, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8gau3o45sfp482nhnrrlj2mo0e